Antibacterial Coatings: Challenges, Perspectives, and Opportunities

Trends in Biotechnology

Volumn 33, Issue 11, 2015, Pages 637-652

  Cloutier, M ^a   Mantovani, D ^a   Rosei, F ^b,c  

^a University Laval   (Canada)

^b INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE   (Canada)

^c UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Antibacterial agent release; Antibacterial coatings; Controlled release; Multifunctional coatings; Stability

Indexed keywords

CONVERGENCE OF NUMERICAL METHODS; ENVIRONMENTAL MICROBIOLOGY;

ANTIBACTERIAL COATINGS; ANTIBACTERIAL PROPERTIES; BACTERIAL PATHOGENS; CONTROLLED RELEASE; LONG TERM STABILITY; MITIGATION STRATEGY; MULTIFUNCTIONAL COATINGS; THERAPEUTIC EFFECTS;

COATINGS;

ANTIINFECTIVE AGENT; SILVER;

DRUG COATING; DRUG RELEASE; DRUG STABILITY; HOSPITAL INFECTION; KINETICS; PRIORITY JOURNAL; REVIEW; STIMULATION; SURFACE PROPERTY; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; ENVIRONMENTAL MICROBIOLOGY; SILVER; SURFACE PROPERTIES;

EID: 84947554487     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2015.09.002     Document Type: Review

References (144)

1. Chilkoti A., Hubbell J.A.E. Biointerface science. MRS Bull. 2005, 30:175-210.
2. McBryde E., et al. An investigation of contact transmission of methicillin-resistant Staphylococcus aureus. J. Hosp. Infect. 2004, 58:104-108.
3. Klevens R.M., et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007, 122:160-166.
4. Rutledge-Taylor K., et al. A point prevalence survey of health care-associated infections in Canadian pediatric inpatients. Am. J. Infect. Control 2012, 40:491-496.
5. Peleg A.Y., Hooper D.C. Hospital-acquired infections due to Gram-negative bacteria. N. Engl. J. Med. 2010, 362:1804-1813.
6. Zarb P., et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro. Surveill. 2012, 17:20316.
7. Allegranzi B., et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 2011, 377:228-241.
8. Pasquarella C., et al. A mobile laminar airflow unit to reduce air bacterial contamination at surgical area in a conventionally ventilated operating theatre. J. Hosp. Infect. 2007, 66:313-319.
9. Magill S.S., et al. Multistate point-prevalence survey of health care-associated infections. N. Engl. J. Med. 2014, 370:1198-1208.
10. Costerton J.W., et al. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
11. Kramer A., et al. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect. Dis. 2006, 6:130.
12. Glinel K., et al. Antibacterial surfaces developed from bio-inspired approaches. Acta Biomater. 2012, 8:1670-1684.
13. Fox J.L. Antimicrobial peptides stage a comeback. Nat. Biotechnol. 2013, 31:379-382.
14. Page K., et al. Antimicrobial surfaces and their potential in reducing the role of the inanimate environment in the incidence of hospital-acquired infections. J. Mater. Chem. 2009, 19:3819-3831.
15. Bartley J.M., Olmsted R.N. Reservoirs of pathogens causing health care-associated infections in the 21st Century: is renewed attention to inanimate surfaces warranted?. Clin. Microbiol. Newsl. 2008, 30:113-117.
16. Salwiczek M., et al. Emerging rules for effective antimicrobial coatings. Trends Biotechnol. 2014, 32:82-90.
17. Green J-B.D., et al. A review of immobilized antimicrobial agents and methods for testing. Biointerphases 2011, 6:MR13-MR28.
18. Banerjee I., et al. Antifouling coatings: recent developments in the design of surfaces that prevent fouling by proteins, bacteria, and marine organisms. Adv. Mater. 2011, 23:690-718.
19. Darouiche R.O., et al. A comparison of two antimicrobial-impregnated central venous catheters. N. Engl. J. Med. 1999, 340:1-8.
20. Rupp M.E., et al. Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am. J. Infect. Control 2004, 32:445-450.
21. Casey A.L., et al. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect. Dis. 2008, 8:763-776.
22. Wang Z., et al. Systematic review and meta-analysis of triclosan-coated sutures for the prevention of surgical-site infection. Br. J. Surg. 2013, 100:465-473.
23. Williams D.L., et al. Characterization of a novel active release coating to prevent biofilm implant-related infections. J. Biomed. Mater. Res. B: Appl. Biomater. 2013, 101:1078-1089.
24. Arvaniti K., et al. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study. Crit. Care Med. 2012, 40:420-429.
25. Tiller J.C. Antimicrobial surfaces. Bioactive Surfaces 2011, 193-217. Springer. H.G. Börner, J.-F. Lutz (Eds.).
26. Lewis K., Klibanov A.M. Surpassing nature: rational design of sterile-surface materials. Trends Biotechnol. 2005, 23:343-348.
27. Imamovic L., Sommer M.O.A. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci. Transl. Med. 2013, 5:204ra132.
28. Ling L.L., et al. A new antibiotic kills pathogens without detectable resistance. Nature 2015, 517:455-459.
29. Sintim H.O., et al. Paradigm shift in discovering next-generation anti-infective agents: targeting quorum sensing, c-di-GMP signaling and biofilm formation in bacteria with small molecules. Future Med. Chem. 2010, 2:1005-1035.
30. Chua S.L., et al. Dispersed cells represent a distinct stage in the transition from bacterial biofilm to planktonic lifestyles. Nat. Commun. 2014, 5:4462.
31. Campoccia D., et al. A review of the biomaterials technologies for infection-resistant surfaces. Biomaterials 2013, 34:8533-8554.
32. Lichter J.A., et al. Design of antibacterial surfaces and interfaces: polyelectrolyte multilayers as a multifunctional platform. Macromolecules 2009, 42:8573-8586.
33. Hetrick E.M., Schoenfisch M.H. Reducing implant-related infections: active release strategies. Chem. Soc. Rev. 2006, 35:780-789.
34. Ng V.W.L., et al. Antimicrobial hydrogels: a new weapon in the arsenal against multidrug-resistant infections. Adv. Drug Deliv. Rev. 2014, 78:46-62.
35. Vasilev K., et al. Antibacterial surfaces and coatings produced by plasma techniques. Plasma Process. Polym. 2011, 8:1010-1023.
36. Bai X., et al. Functionally graded hydroxyapatite coatings doped with antibacterial components. Acta Biomater. 2010, 6:2264-2273.
37. Ivanova K., et al. Enzyme multilayer coatings inhibit Pseudomonas aeruginosa biofilm formation on urinary catheters. Appl. Microbiol. Biotechnol. 2015, 99:4373-4385.
38. Baveja J.K., et al. Furanones as potential anti-bacterial coatings on biomaterials. Biomaterials 2004, 25:5003-5012.
39. Anguita-Alonso P., et al. RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation. Antimicrob. Agents Chemother. 2007, 51:2594-2596.
40. Barraud N., et al. Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal. J. Bacteriol. 2009, 191:7333-7342.
41. Hetrick E.M., et al. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials 2009, 30:2782-2789.
42. Charville G.W., et al. Reduced bacterial adhesion to fibrinogen-coated substrates via nitric oxide release. Biomaterials 2008, 29:4039-4044.
43. Busscher H.J., et al. Biomaterial-associated infection: locating the finish line in the race for the surface. Sci. Transl. Med. 2012, 4:153rv110.
44. Zarie E.S., et al. Solvent free fabrication of micro and nanostructured drug coatings by thermal evaporation for controlled release and increased effects. PLoS ONE 2012, 7:e40746.
45. Cheng H., et al. Long-lasting in vivo and in vitro antibacterial ability of nanostructured titania coating incorporated with silver nanoparticles. J. Biomed. Mater. Res. A 2014, 102:3488-3499.
46. Hughes G.A. Nanostructure-mediated drug delivery. Nanomedicine 2005, 1:22-30.
47. Hsu B.B., et al. Multimonth controlled small molecule release from biodegradable thin films. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:12175-12180.
48. Jo Y.S., et al. Tailoring hydrogel degradation and drug release via neighboring amino acid controlled ester hydrolysis. Soft Matter 2009, 5:440-446.
49. Kwok C.S., et al. Design of infection-resistant antibiotic-releasing polymers. II. Controlled release of antibiotics through a plasma-deposited thin film barrier. J. Control. Release 1999, 62:301-311.
50. Yin B., et al. Prolonging the duration of preventing bacterial adhesion of nanosilver-containing polymer films through hydrophobicity. Langmuir 2012, 28:17019-17025.
51. Hagiwara K., et al. Effects of plasma treatments on the controlled drug release from poly(ethylene-co-vinyl acetate). Surf. Coat. Tech. 2013, 216:318-323.
52. Alarcon C.d.l.H., et al. Stimuli responsive polymers for biomedical applications. Chem. Soc. Rev. 2005, 34:276-285.
53. Stuart M.A.C., et al. Emerging applications of stimuli-responsive polymer materials. Nat. Mater. 2010, 9:101-113.
54. Roy D., et al. Future perspectives and recent advances in stimuli-responsive materials. Prog. Polym. Sci. 2010, 35:278-301.
55. Esrafilzadeh D., et al. Multifunctional conducting fibres with electrically controlled release of ciprofloxacin. J. Control. Release 2013, 169:313-320.
56. Hu B., et al. Core-shell-shell nanorods for controlled release of silver that can serve as a nanoheater for photothermal treatment on bacteria. Acta Biomater. 2015, 11:511-519.
57. Norris P., et al. Ultrasonically controlled release of ciprofloxacin from self-assembled coatings on poly(2-hydroxyethyl methacrylate) hydrogels for Pseudomonas aeruginosa biofilm prevention. Antimicrob. Agents Chemother. 2005, 49:4272-4279.
58. Noble M.L., et al. Digital drug delivery: on-off ultrasound controlled antibiotic release from coated matrices with negligible background leaching. Biomater. Sci. 2014, 2:893-902.
59. Wang H., et al. Magnetic/NIR-thermally responsive hybrid nanogels for optical temperature sensing, tumor cell imaging and triggered drug release. Nanoscale 2014, 6:13001-13011.
60. Shchukin D.G., Möhwald H. Self-repairing coatings containing active nanoreservoirs. Small 2007, 3:926-943.
61. Gerber L.C., et al. Incorporation of penicillin-producing fungi into living materials to provide chemically active and antibiotic-releasing surfaces. Angew. Chem. 2012, 124:11455-11458.
62. Borges J., et al. Layer-by-layer assembly of light-responsive polymeric multilayer systems. Adv. Funct. Mater. 2014, 24:5624-5648.
63. Black K.C.L., et al. Bacterial killing by light-triggered release of silver from biomimetic metal nanorods. Small 2014, 10:169-178.
64. Gallo J., et al. Antibacterial surface treatment for orthopaedic implants. Int. J. Mol. Sci. 2014, 15:13849-13880.
65. Shchukin D., Möhwald H. A coat of many functions. Science 2013, 341:1458-1459.
66. Traba C., Liang J.F. Bacteria responsive antibacterial surfaces for indwelling device infections. J. Control. Release 2015, 198:18-25.
67. Zhuk I., et al. Self-defensive layer-by-layer films with bacteria-triggered antibiotic release. ACS Nano 2014, 8:7733-7745.
68. Pavlukhina S., et al. Polymer multilayers with pH-triggered release of antibacterial agents. Biomacromolecules 2010, 11:3448-3456.
69. Pavlukhina S., et al. Small-molecule-hosting nanocomposite films with multiple bacteria-triggered responses. NPG Asia Mater. 2014, 6:e121.
70. Pichavant L., et al. pH-controlled delivery of gentamicin sulfate from orthopedic devices preventing nosocomial infections. J. Control. Release 2012, 162:373-381.
71. Tanihara M., et al. A novel microbial infection-responsive drug release system. J. Pharm. Sci. 1999, 88:510-514.
72. Komnatnyy V.V., et al. Bacteria-triggered release of antimicrobial agents. Angew. Chem. 2014, 126:449-451.
73. Cado G., et al. Self-defensive biomaterial coating against bacteria and yeasts: polysaccharide multilayer film with embedded antimicrobial peptide. Adv. Funct. Mater. 2013, 23:4801-4809.
74. Cottarel G., Wierzbowski J. Combination drugs, an emerging option for antibacterial therapy. Trends Biotechnol. 2007, 25:547-555.
75. Raad I., et al. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J. Infect. Dis. 1996, 173:418-424.
76. Kohnen W., et al. Development of a long-lasting ventricular catheter impregnated with a combination of antibiotics. Biomaterials 2003, 24:4865-4869.
77. Holzapfel B.M., et al. How smart do biomaterials need to be? A translational science and clinical point of view. Adv. Drug Deliv. Rev. 2013, 65:581-603.
78. Fayaz A.M., et al. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. Nanomedicine 2010, 6:103-109.
79. Varisco M., et al. New antimicrobial and biocompatible implant coating with synergic silver-vancomycin conjugate action. ChemMedChem 2014, 9:1221-1230.
80. Storm W.L., et al. Dual action antimicrobial surfaces via combined nitric oxide and silver release. J. Biomed. Mater. Res. A 2015, 103:1974-1984.
81. Morones-Ramirez J.R., et al. Silver enhances antibiotic activity against gram-negative bacteria. Sci. Transl. Med. 2013, 5:190ra181.
82. Samani S., et al. In vitro antibacterial evaluation of sol-gel-derived Zn-, Ag-, and (Zn + Ag)-doped hydroxyapatite coatings against methicillin-resistant Staphylococcus aureus. J. Biomed. Mater. Res. A 2013, 101:222-230.
83. Li Z., et al. Two-level antibacterial coating with both release-killing and contact-killing capabilities. Langmuir 2006, 22:9820-9823.
84. Worley B.V., et al. Nitric oxide-releasing quaternary ammonium-modified poly(amidoamine) dendrimers as dual action antibacterial agents. Bioconjugate Chem. 2014, 25:918-927.
85. Ho C.H., et al. Nanoseparated polymeric networks with multiple antimicrobial properties. Adv. Mater. 2004, 16:957-961.
86. Hu R., et al. Silver-zwitterion organic-inorganic nanocomposite with antimicrobial and antiadhesive capabilities. Langmuir 2013, 29:3773-3779.
87. Yu Q., et al. Dual-function antibacterial surfaces for biomedical applications. Acta Biomater. 2015, 16:1-13.
88. Jia W.Y., et al. Nickel release from orthodontic arch wires and cellular immune response to various nickel concentrations. J. Biomed. Mater. Res. 1999, 48:488-495.
89. Poitout D.G., et al. Biomechanics and Biomaterials in Orthopedics 2004, Springer.
90. Variola F., et al. Improving biocompatibility of implantable metals by nanoscale modification of surfaces: an overview of strategies, fabrication methods, and challenges. Small 2009, 5:996-1006.
91. Jin G., et al. Synergistic effects of dual Zn/Ag ion implantation in osteogenic activity and antibacterial ability of titanium. Biomaterials 2014, 35:7699-7713.
92. Cloutier M., et al. On the long term antibacterial features of silver-doped diamondlike carbon coatings deposited via a hybrid plasma process. Biointerphases 2014, 9:029013.
93. Goodman S.B., et al. The future of biologic coatings for orthopaedic implants. Biomaterials 2013, 34:3174-3183.
94. Zhao L., et al. Antibacterial nano-structured titania coating incorporated with silver nanoparticles. Biomaterials 2011, 32:5706-5716.
95. Chua P-H., et al. Surface functionalization of titanium with hyaluronic acid/chitosan polyelectrolyte multilayers and RGD for promoting osteoblast functions and inhibiting bacterial adhesion. Biomaterials 2008, 29:1412-1421.
96. Chen D., et al. Robust, flexible, and bioadhesive free-standing films for the co-delivery of antibiotics and growth factors. Langmuir 2014, 30:13898-13906.
97. Wong S.Y., et al. Dual functional polyelectrolyte multilayer coatings for implants: permanent microbicidal base with controlled release of therapeutic agents. J. Am. Chem. Soc. 2010, 132:17840-17848.
98. Frost M.C., et al. Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting medical devices. Biomaterials 2005, 26:1685-1693.
99. Carpenter A.W., Schoenfisch M.H. Nitric oxide release, Part II. Therapeutic applications. Chem. Soc. Rev. 2012, 41:3742-3752.
100. Tugulu S., Klok H-A. Stability and nonfouling properties of poly(poly(ethylene glycol) methacrylate) brushes under cell culture conditions. Biomacromolecules 2008, 9:906-912.
101. Pidhatika B., et al. Comparative stability studies of poly(2-methyl-2-oxazoline) and poly(ethylene glycol) brush coatings. Biointerphases 2012, 7:1-15.
102. Roosjen A., et al. Stability and effectiveness against bacterial adhesion of poly(ethylene oxide) coatings in biological fluids. J. Biomed. Mater. Res. B 2005, 73:347-354.
103. Hasan J., et al. Antibacterial surfaces: the quest for a new generation of biomaterials. Trends Biotechnol. 2013, 31:295-304.
104. Ramsden J.J., et al. The design and manufacture of biomedical surfaces. CIRP Ann. Manuf. Technol. 2007, 56:687-711.
105. Thom K.A., et al. Effectiveness of an antimicrobial polymer to decrease contamination of environmental surfaces in the clinical setting. Infect. Cont. Hosp. Ep. 2014, 35:1060-1062.
106. Airey P., Verran J. Potential use of copper as a hygienic surface; problems associated with cumulative soiling and cleaning. J. Hosp. Infect. 2007, 67:271-277.
107. Lewis F., et al. Influence of the 316 L stainless steel interface on the stability and barrier properties of plasma fluorocarbon films. ACS Appl. Mater. Interfaces 2011, 3:2323-2331.
108. Cloutier M., et al. Long-term stability of hydrogenated DLC coatings: Effects of aging on the structural, chemical and mechanical properties. Diam. Relat. Mater. 2014, 48:65-72.
109. 2/Cu films by HiPIMS for accelerated bacterial loss of viability. Surf. Coat. Tech. 2013, 232:804-813.
110. Duday D., et al. Atmospheric pressure plasma modified surfaces for immobilization of antimicrobial nisin peptides. Surf. Coat. Tech. 2013, 218:152-161.
111. Roy M., et al. Mechanical, in vitro antimicrobial, and biological properties of plasma-sprayed silver-doped hydroxyapatite coating. ACS Appl. Mater. Interfaces 2012, 4:1341-1349.
112. Weber D.J., Rutala W.A. Self-disinfecting surfaces: review of current methodologies and future prospects. Am. J. Infect. Control 2013, 41:S31-S35.
113. Grainger D.W., et al. Critical factors in the translation of improved antimicrobial strategies for medical implants and devices. Biomaterials 2013, 34:9237-9243.
114. Moriarty T., et al. Challenges in linking preclinical anti-microbial research strategies with clinical outcomes for device-associated infections. Eur. Cell Mater. 2014, 28:112-128.
115. Tiller J.C., et al. Designing surfaces that kill bacteria on contact. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:5981-5985.
116. Dunne W.M. Bacterial adhesion: seen any good biofilms lately?. Clin. Microbiol. Rev. 2002, 15:155-166.
117. Friedlander R.S., et al. Bacterial flagella explore microscale hummocks and hollows to increase adhesion. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:5624-5629.
118. Variola F., et al. Oxidative nanopatterning of titanium generates mesoporous surfaces with antimicrobial properties. Int. J. Nanomed. 2014, 9:2319-2325.
119. Zilberman M., Elsner J.J. Antibiotic-eluting medical devices for various applications. J. Control. Release 2008, 130:202-215.
120. Kazemzadeh-Narbat M., et al. Multilayered coating on titanium for controlled release of antimicrobial peptides for the prevention of implant-associated infections. Biomaterials 2013, 34:5969-5977.
121. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 2005, 3:238-250.
122. Chaloupka K., et al. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 2010, 28:580-588.
123. Eckhardt S., et al. Nanobio silver: its interactions with peptides and bacteria, and its uses in medicine. Chem. Rev. 2013, 113:4708-4754.
124. Lemire J.A., et al. Antimicrobial activity of metals: mechanisms, molecular targets and applications. Nat. Rev. Microbiol. 2013, 11:371-384.
125. Kelson A.B., et al. Gallium-based anti-infectives: targeting microbial iron-uptake mechanisms. Curr. Opin. Pharmacol. 2013, 13:707-716.
126. Tran P.A., Webster T.J. Antimicrobial selenium nanoparticle coatings on polymeric medical devices. Nanotechnology 2013, 24:155101.
127. Rodríguez-Valencia C., et al. Novel selenium-doped hydroxyapatite coatings for biomedical applications. J. Biomed. Mater. Res. A 2013, 101:853-861.
128. Shirai T., et al. Antibacterial iodine-supported titanium implants. Acta Biomater. 2011, 7:1928-1933.
129. Eby D.M., et al. Hybrid antimicrobial enzyme and silver nanoparticle coatings for medical instruments. ACS Appl. Mater. Interfaces 2009, 1:1553-1560.
130. Zhou B., et al. Antibacterial multilayer films fabricated by layer-by-layer immobilizing lysozyme and gold nanoparticles on nanofibers. Colloids Surf. B: Biointerfaces 2014, 116:432-438.
131. Carmona-Ribeiro A.M., de Melo Carrasco L.D. Cationic antimicrobial polymers and their assemblies. Int. J. Mol. Sci. 2013, 14:9906-9946.
132. Zhao L., et al. Antibacterial coatings on titanium implants. J. Biomed. Mater. Res. B 2009, 91B:470-480.
133. Baier G., et al. Enzymatic degradation of poly(l-lactide) nanoparticles followed by the release of octenidine and their bactericidal effects. Nanomedicine 2014, 10:131-139.
134. Vasilev K., et al. Antibacterial surfaces for biomedical devices. Expert Rev. Med. Devices 2009, 6:553-567.
135. Michl T.D., et al. Nitric oxide releasing plasma polymer coating with bacteriostatic properties and no cytotoxic side effects. Chem. Commun. 2015, 51:7058-7060.
136. Seddiki O., et al. Evidence of antibacterial activity on titanium surfaces through nanotextures. Appl. Surf. Sci. 2014, 308:275-284.
137. Thatiparti T.R., et al. Cyclodextrin-based device coatings for affinity-based release of antibiotics. Biomaterials 2010, 31:2335-2347.
138. Vasilev K., et al. Tunable antibacterial coatings that support mammalian cell growth. Nano Lett. 2009, 10:202-207.
139. Chu P.K., et al. Plasma-surface modification of biomaterials. Mat. Sci. Eng. R 2002, 36:143-206.
140. Martin P.M. Handbook of Deposition Technologies for Films and Coatings: Science, Technology and Applications 2010, William Andrew Publishing. 3rd edn.
141. Serrano C., et al. Nanostructured medical sutures with antibacterial properties. Biomaterials 2015, 52:291-300.
142. Zhao Y., et al. Enhanced antimicrobial properties, cytocompatibility, and corrosion resistance of plasma-modified biodegradable magnesium alloys. Acta Biomater. 2014, 10:544-556.
143. Zimmermann R., et al. An approach to create silver containing antibacterial coatings by use of atmospheric pressure plasma chemical vapour deposition (APCVD) and combustion chemical vapour deposition (CCVD) in an economic way. Plasma Process. Polym. 2011, 8:295-304.
144. Vaz J.M., et al. Covalent grafting of chitosan on plasma-treated polytetrafluoroethylene surfaces for biomedical applications. J. Biomater. Tiss. Eng. 2014, 4:915-924.